327 related articles for article (PubMed ID: 32896294)
1. Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT): a randomised, double-blind, controlled trial.
Richards T; Baikady RR; Clevenger B; Butcher A; Abeysiri S; Chau M; Macdougall IC; Murphy G; Swinson R; Collier T; Van Dyck L; Browne J; Bradbury A; Dodd M; Evans R; Brealey D; Anker SD; Klein A
Lancet; 2020 Oct; 396(10259):1353-1361. PubMed ID: 32896294
[TBL] [Abstract][Full Text] [Related]
2. Preoperative intravenous iron for anaemia in elective major open abdominal surgery: the PREVENTT RCT.
Richards T; Baikady RR; Clevenger B; Butcher A; Abeysiri S; Chau M; Swinson R; Collier T; Dodd M; Dyck LV; Macdougall I; Murphy G; Browne J; Bradbury A; Klein A
Health Technol Assess; 2021 Feb; 25(11):1-58. PubMed ID: 33632377
[TBL] [Abstract][Full Text] [Related]
3. Ferric derisomaltose and tranexamic acid, combined or alone, for reducing blood transfusion in patients with hip fracture (the HiFIT trial): a multicentre, 2 × 2 factorial, randomised, double-blind, controlled trial.
Lasocki S; Capdevila X; Vielle B; Bijok B; Lahlou-Casulli M; Collange V; Grillot N; Danguy des Deserts M; Duchalais A; Delannoy B; Drugeon B; Bouzat P; David JS; Rony L; Loupec T; Léger M; Rineau E; ;
Lancet Haematol; 2023 Sep; 10(9):e747-e755. PubMed ID: 37524101
[TBL] [Abstract][Full Text] [Related]
4. PREVENTT: preoperative intravenous iron to treat anaemia in major surgery: study protocol for a randomised controlled trial.
Richards T; Clevenger B; Keidan J; Collier T; Klein AA; Anker SD; Kelly JD
Trials; 2015 Jun; 16():254. PubMed ID: 26041028
[TBL] [Abstract][Full Text] [Related]
5. The PREVENNT randomised, double-blind, controlled trial of preoperative intravenous iron to treat anaemia before major abdominal surgery: an independent discussion.
Abbott TEF; Gillies MA
Br J Anaesth; 2021 Jan; 126(1):157-162. PubMed ID: 33066972
[TBL] [Abstract][Full Text] [Related]
6. Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial.
Khalafallah AA; Yan C; Al-Badri R; Robinson E; Kirkby BE; Ingram E; Gray Z; Khelgi V; Robertson IK; Kirkby BP
Lancet Haematol; 2016 Sep; 3(9):e415-25. PubMed ID: 27570088
[TBL] [Abstract][Full Text] [Related]
7. Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial.
Spahn DR; Schoenrath F; Spahn GH; Seifert B; Stein P; Theusinger OM; Kaserer A; Hegemann I; Hofmann A; Maisano F; Falk V
Lancet; 2019 Jun; 393(10187):2201-2212. PubMed ID: 31036337
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallel-group, open-label, randomised controlled phase 3 trial.
Vanobberghen F; Lweno O; Kuemmerle A; Mwebi KD; Asilia P; Issa A; Simon B; Mswata S; Schmidlin S; Glass TR; Abdulla S; Daubenberger C; Tanner M; Meyer-Monard S
Lancet Glob Health; 2021 Feb; 9(2):e189-e198. PubMed ID: 33245866
[TBL] [Abstract][Full Text] [Related]
9. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.
Ponikowski P; Kirwan BA; Anker SD; McDonagh T; Dorobantu M; Drozdz J; Fabien V; Filippatos G; Göhring UM; Keren A; Khintibidze I; Kragten H; Martinez FA; Metra M; Milicic D; Nicolau JC; Ohlsson M; Parkhomenko A; Pascual-Figal DA; Ruschitzka F; Sim D; Skouri H; van der Meer P; Lewis BS; Comin-Colet J; von Haehling S; Cohen-Solal A; Danchin N; Doehner W; Dargie HJ; Motro M; Butler J; Friede T; Jensen KH; Pocock S; Jankowska EA;
Lancet; 2020 Dec; 396(10266):1895-1904. PubMed ID: 33197395
[TBL] [Abstract][Full Text] [Related]
10.
Bisch SP; Woo L; Ljungqvist O; Nelson G
BMJ Open; 2023 Nov; 13(11):e074649. PubMed ID: 37945297
[TBL] [Abstract][Full Text] [Related]
11. Intravenous iron administration before cardiac surgery reduces red blood cell transfusion in patients without anaemia.
Friedman T; Dann EJ; Bitton-Worms K; Makhoul M; Glam R; Weis A; Tam DY; Bolotin G
Br J Anaesth; 2023 Dec; 131(6):981-988. PubMed ID: 37838604
[TBL] [Abstract][Full Text] [Related]
12. Evidence cornered: Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT trial).
Aaron L; Day J; Shah A
Transfus Med; 2021 Oct; 31(5):311-313. PubMed ID: 34184336
[TBL] [Abstract][Full Text] [Related]
13. Iron therapy for pre-operative anaemia.
Ng O; Keeler BD; Mishra A; Simpson A; Neal K; Brookes MJ; Acheson AG
Cochrane Database Syst Rev; 2015 Dec; (12):CD011588. PubMed ID: 26694949
[TBL] [Abstract][Full Text] [Related]
14. The impact of pre-operative intravenous iron on quality of life after colorectal cancer surgery: outcomes from the intravenous iron in colorectal cancer-associated anaemia (IVICA) trial.
Keeler BD; Dickson EA; Simpson JA; Ng O; Padmanabhan H; Brookes MJ; Acheson AG;
Anaesthesia; 2019 Jun; 74(6):714-725. PubMed ID: 30963552
[TBL] [Abstract][Full Text] [Related]
15. Intravenous iron isomaltoside 1000 (Monofer®) reduces postoperative anaemia in preoperatively non-anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double-blind placebo-controlled clinical trial (the PROTECT trial).
Johansson PI; Rasmussen AS; Thomsen LL
Vox Sang; 2015 Oct; 109(3):257-66. PubMed ID: 25900643
[TBL] [Abstract][Full Text] [Related]
16. Intravenous iron does not effectively correct preoperative anaemia in cardiac surgery: a pilot randomized controlled trial.
Padmanabhan H; Siau K; Nevill AM; Morgan I; Cotton J; Ng A; Brookes MJ; Luckraz H
Interact Cardiovasc Thorac Surg; 2019 Mar; 28(3):447-454. PubMed ID: 30107449
[TBL] [Abstract][Full Text] [Related]
17. Preoperative intravenous iron before cardiac surgery: a prospective multicentre feasibility study.
Klein AA; Chau M; Yeates JA; Collier T; Evans C; Agarwal S; Richards T;
Br J Anaesth; 2020 Mar; 124(3):243-250. PubMed ID: 31902590
[TBL] [Abstract][Full Text] [Related]
18. Safety and effectiveness of intravenous iron sucrose versus standard oral iron therapy in pregnant women with moderate-to-severe anaemia in India: a multicentre, open-label, phase 3, randomised, controlled trial.
Neogi SB; Devasenapathy N; Singh R; Bhushan H; Shah D; Divakar H; Zodpey S; Malik S; Nanda S; Mittal P; Batra A; Chauhan MB; Yadav S; Dongre H; Saluja S; Malhotra V; Gupta A; Sangwan R; Radhika AG; Singh A; Bhaskaran S; Kotru M; Sikka M; Agarwal S; Francis P; Mwinga K; Baswal D
Lancet Glob Health; 2019 Dec; 7(12):e1706-e1716. PubMed ID: 31708151
[TBL] [Abstract][Full Text] [Related]
19. Ferric carboxymaltose versus standard-of-care oral iron to treat second-trimester anaemia in Malawian pregnant women: a randomised controlled trial.
Pasricha SR; Mwangi MN; Moya E; Ataide R; Mzembe G; Harding R; Zinenani T; Larson LM; Demir AY; Nkhono W; Chinkhumba J; Simpson JA; Clucas D; Stones W; Braat S; Phiri KS
Lancet; 2023 May; 401(10388):1595-1609. PubMed ID: 37088092
[TBL] [Abstract][Full Text] [Related]
20. The association between iron deficiency and outcomes: a secondary analysis of the intravenous iron therapy to treat iron deficiency anaemia in patients undergoing major abdominal surgery (PREVENTT) trial.
Richards T; Miles LF; Clevenger B; Keegan A; Abeysiri S; Rao Baikady R; Besser MW; Browne JP; Klein AA; Macdougall IC; Murphy GJ; Anker SD; Dahly D;
Anaesthesia; 2023 Mar; 78(3):320-329. PubMed ID: 36477695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
